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ABSTRACT
Wrist fractures are common in postmenopausal women and are associated with functional decline. Fracture patterns after wrist
fracture are unclear. The goal of this study was to determine the frequency and types of fractures that occur after a wrist fracture
among postmenopausal women. We carried out a post hoc analysis of data from the Women’s Health Initiative Observational Study
and Clinical Trials (1993–2010) carried out at 40 US clinical centers. Participants were postmenopausal women aged 50 to 79 years at
baseline. Mean follow-up duration was 11.8 years. Main measures included incident wrist, clinical spine, humerus, upper extremity,
lower extremity, hip, and total non-wrist fractures and bone mineral density (BMD) in a subset. Among women who experienced
wrist fracture, 15.5% subsequently experienced non-wrist fracture. The hazard for non-wrist fractures was higher among women
who had experienced previous wrist fracture than amongwomenwho had not experienced wrist fracture: non-wrist fracture overall
(hazard ratio [HR]¼ 1.40, 95% confidence interval [CI] 1.33–1.48), spine (HR¼ 1.48, 95% CI 1.32–1.66), humerus (HR¼ 1.78, 95% CI
1.57–2.02), upper extremity (non-wrist) (HR¼ 1.88, 95% CI 1.70–2.07), lower extremity (non-hip) (HR¼ 1.36, 95% CI 1.26–1.48), and
hip (HR¼ 1.50, 95% CI 1.32–1.71) fracture. Associations persisted after adjustment for BMD, physical activity, and other risk factors.
Risk of non-wrist fracture was higher in women who were younger when they experienced wrist fracture (interaction p value 0.02).
Associations between incident wrist fracture and subsequent non-wrist fracture did not vary by baseline BMD category (normal, low
bone density, osteoporosis). A wrist fracture is associated with increased risk of subsequent hip, vertebral, upper extremity, and
lower extremity fractures. There may be substantial missed opportunity for intervention in the large number of womenwho present
with wrist fractures. © 2015 American Society for Bone and Mineral Research.
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Introduction
The incidence of wrist and distal forearm fracture increasesexponentially with age among women aged 50 years.(1–6)
Wrist fractures are the most common type of clinical fracture
among US women aged younger than 65 years.(7,8) Moreover,
wrist fractures are associated with functional decline.(9) In the
5 years after a distal forearm fracture, the risk of mortality ranges
from 12% among women aged 65 and 74 years to 43% for
women aged 85þ.(10) However, the current National Osteopo-
rosis Foundation guidelines do not consider wrist fractures by
themselves (in persons without prior hip or vertebral fracture or
bone mineral density in the osteoporosis range) to be an
indication for pharmacotherapy.(11) In a recent position
statement from the National Bone Health Alliance Working
Group based on expert opinion, distal forearm fractures are
characterized as osteoporotic fractures only if there is
concomitant osteopenia (T-score between –1.0 and –2.5) on a
lumbar spine or hip bone mineral density (BMD) measure-
ment.(12) Therefore, there is a lack of consensus among
specialized bone societies regarding whether non-traumatic
wrist fractures should be considered fragility fractures.
Prospective Canadian,(13) Taiwanese,(14) and Danish(15) studies
have reported higher risk of future fractures amongwomenwith
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wrist fractures compared with expected background population
rates, but there are few US studies. One US study found higher
observed rates of fracture, compared with expected rates,
subsequent to an initial wrist fracture among inhabitants of
Rochester, MN.(1,16) In the prospective National Osteoporosis Risk
Assessment Program (NORA), wrist fractures were associated with
increased risk of subsequent osteoporotic fracture,(17,18) but the
study durationwas only 3 years, and detailed description of specific
anatomic fracture sites of the subsequent fractures was not
provided. Both studies showed increased risk of subsequent
fracture in women who experienced an initial wrist fracture
comparedwithwomenwhodidnotexperience initialwrist fracture.
Understanding the frequency, timing, and types of fractures
that occur after an initial wrist fracture can help to address
unmet opportunities for prevention of subsequent fractures and
functional decline. The goal of the current study was to
determine, among postmenopausal women, the associations
between wrist fracture and subsequent fracture incidence,
according to anatomical site and age and, in a subgroup of
participants, femoral neck BMD. We hypothesized that wrist
fracture would be strongly associated with increased incidence
of subsequent fracture at each anatomical site examined.
Materials and Methods
Participants
For the current study, analyses of associations between incident
wrist fracture and subsequent fractures were performed using
data from participants of the Women’s Health Initiative
Observational Study (WHI-OS) and WHI Clinical Trials (WHI-CT).
The WHI, carried out at 40 US clinical centers, is a study of
postmenopausal women aged 50 to 79 years and free of serious
medical conditions at baseline.(19–22) The WHI-OS was designed
to examine important causes of morbidity and mortality in
postmenopausal women.(20) The WHI-CTs examined the effects
of menopausal hormone therapy (WHI Hormone Therapy Trials),
calcium and vitamin D supplementation (WHI CaD Trial), and a
low-fat eating pattern (WHI Dietary Modification Trial). (19) The
WHI-OS and WHI-CT main studies were conducted between
1993 and 2005. Of 150,076 participants who were in active
follow-up at the end of the main studies, 76.9% consented to
participate in an extension study conducted between 2005
and 2010.
Of the 93,676 WHI-OS participants and 68,132 WHI-CT
participants enrolled, we excluded data from 878 participants
who provided no follow-up information, resulting in an analytic
sample of 160,930 participants (93,049 WHI-OS, 67,881 WHI-CT
participants) (Fig. 1). Participants reporting a history of prior
fractures were not excluded from the current study.
To examine the influence of adjusting for BMD on the
associations between initial wrist fracture and subsequent
fracture, we used data from the WHI Bone Mineral Density
Cohort. At enrollment, participants at three of the 40 clinical
centers (Tucson/Phoenix, AZ; Pittsburgh, PA; Birmingham, AL)
underwent hip and lumbar spine dual-energy X-ray absorpti-
ometry. Quality-assurancemethods included standard protocols
for positioning and analysis, cross-clinic calibration phantoms,
Fig. 1. STROBE flow diagram of the analytic sample.
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further evaluation of scans with specific problems, and review of
a random sample of scans.(23–25)
Of the 11,434 participants of the WHI BMD Cohort, 11,350
underwent at least one BMDmeasurement (lumbar spine and/or
hip) at baseline and at least one follow-up assessment. Thus, the
sample size for the BMD analysis was 11,350 participants.
Each institution obtained human subjects committee approv-
al. All participants provided written informed consent.
Outcomes: fracture incidence and BMD
Information regarding incident fractures was obtained semian-
nually for the WHI-CT and annually for the WHI-OS. At each
assessment, questionnaires asked whether participants had
experienced fracture events since the previous visit: “Has a
doctor told you for the first time that you have a new broken,
fractured, or crushed bone? Which bone(s) did you break,
fracture, or crush?” Response choices included: hip, upper leg
(not hip), pelvis, knee (patella), lower leg or ankle, foot (not toe),
tailbone (coccyx), spine or back (vertebra), upper arm or
shoulder, elbow, lower arm or wrist, hand (not finger), finger
or toe, jaw, nose, face, and/or skull, ribs and/or chest or breast
bone, and “other.”
All hip fractures were adjudicated by trained staff using
medical record review for both WHI-OS and WHI-CTs, but the
adjudication of non-hip fractures was limited to a subset of
participants during themainWHI study,(26) including 1) fractures
among participants of the WHI Clinical Trials and 2) fractures
among participants in the WHI BMD Cohort. Any fractures that
occurred during the WHI Extension 1 phase in the WHI-OS and
WHI-CTs were self-reported
We defined wrist fracture as first incident fracture of the
forearm (radius or ulna) or carpal bones through the end of WHI
Extension 1. We defined non-wrist fractures as first occurrence of
clinical spine, humerus, upper extremity non-wrist (elbow, hand
[except fingers], upper arm/humerus, shoulder), lower extremity
non-hip (foot [except toes], knee/patella, upper leg, lower leg/
ankle), or hip.
Other measures
We obtained information regarding age, race/ethnicity, educa-
tion, family income, previous fracture, history of cancer, self-
rated health, falls, alcohol consumption, smoking, physical
activity, dietary supplement use, and medication use (including
estrogen therapy and osteoporosis medications) from baseline
self-assessment questionnaires. Baseline physical activity level
was assessed using a validated scale.(27) Food frequency
questionnaires were used to assess dietary calcium and vitamin
D intake.(28) Baseline physical function was assessed by the
36-item Short-Form Health Survey (SF-36).(29,30)
The estimated 10-year risk of major osteoporotic fracture was
calculated by the World Health Organization Collaborating
Centre using the US Fracture Risk Assessment tool (FRAX)
without BMD (version 3.0).(31)
Participant weight and height were measured at baseline
using standardized protocols.
Statistical analysis
We examined baseline characteristics of participants overall and
by subgroup of incident wrist fracture during WHI follow-up
(yes versus no). We calculated the annualized rate of non-wrist
fracture (per 1000 person-years) overall and by 5-year intervals.
We determined the association between non-wrist fracture
and prior wrist fracture using Cox proportional hazards models
that included the occurrence of an initial incident wrist fracture
as the time-varying binary exposure variable (yes versus no
[reference]), adjusting for baseline covariates selected a priori
based on known fracture risk factors: age, race, BMI, education,
income, cigarette smoking status (never, past, current), pack-
years of cigarette smoking, physical activity (total metabolic
equivalent of task h/wk), dietary calcium intake (mg/d), calcium
supplement intake (mg/d), dietary vitamin D intake (IU/d),
vitamin D supplement intake (IU/d), WHI-Hormone Therapy
Trials treatment assignment, and WHI Dietary Modification Trial
Treatment Assignment.
We included an interaction term in the Cox regression model
described above to examine whether associations between
wrist fracture and time to non-wrist fracture depended on age.
We made the a priori decision to test whether associations
varied by race/ethnicity, physical activity level, physical function,
falls, FRAX score without BMD, and lowest femoral neck BMD
category (T-score –1.0, T-score between –1.0 and –2.5,
T-score –2.5) by including cross-product terms of these factors
with wrist fracture in the regression models.
The interval between wrist fracture and subsequent fractures
at other sites was estimated using cumulative incidence curves
computed as complements of Kaplan-Meier survival estimates.
We performed a sensitivity analysis in which we excluded
women who reported taking osteoporosis medication (alendr-
onate, risedronate, zoledronic acid, calcitonin, selective estro-
gen receptor modulators, or denosumab) at any time during the
study, as well as participants who reported taking self-assigned
menopausal hormone therapy any time during the study period,
participants assigned to menopausal hormone therapy, and
participants assigned to the active arm of the WHI Ca/D trial
(resulting sample size 37,931). In another sensitivity analysis, we
defined a combined outcome as time to either fracture or death.
In a final sensitivity analysis, we examined associations
between wrist fracture and subsequent fracture among
participants in whom fractures were adjudicated by medical
record review (ie, WHI-OS participants in the BMD cohort and
WHI-CT participants).
Using data from the WHI BMD Cohort (n¼ 11,350), we
examined the influence of adjusting for baseline BMD on the
magnitude of associations between non-wrist fracture and prior
wrist fracture. We used Cox models as described above and
included baseline femoral neck BMD as a covariate.
Data analysis was performed using SAS 9.3 (SAS Institute,
Cary, NC, USA).
Results
Participant characteristics and rates of fracture during
follow-up
On average, participants were aged 63.2 years and 82.9% were
white (Table 1). At baseline, mean BMI was 28.0, 40.2% were
taking menopausal hormone therapy at baseline, 7.0%
were current smokers, 48.0% were using supplemental vitamin
D, and 8.3% of participants had fallen 2 times in the year prior to
baseline. At baseline 2.0% of participants were taking
bisphosphonates and the prevalence of the use of selective
estrogen receptor modulators, calcitonin, aromatase inhibitors,
tamoxifen, antidepressants, proton pump inhibitors, oral
corticosteroids, and thiazolidinediones was low (Supplemental
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Table 1. Baseline Characteristics, by Wrist Fracture, Among WHI CT and OS Participantsa
Wrist fractureb
Total No Yes
160,930 152,138 8792
N (%) n (%) n (%) p Value
Age (years)
Mean SD 63.2 (7.2) 63.2 (7.2) 64.6 (7.2) <0.001
<55 21,430 (13.3) 20,570 (13.5) 860 (9.8) <0.001
55–59 31,804 (19.8) 30,325 (19.9) 1479 (16.8)
60–64 37,016 (23.0) 35,163 (23.1) 1853 (21.1)
65–69 35,227 (21.9) 33,013 (21.7) 2214 (25.2)
70–74 24,781 (15.4) 23,175 (15.2) 1606 (18.3)
75–79 10,672 (6.6) 9892 (6.5) 780 (8.9)
Ethnicity
White 133,032 (82.9) 125,059 (82.4) 7973 (90.9) <0.001
Black or African-American 14,469 (9.0) 14,159 (9.3) 310 (3.5)
Hispanic/Latino 6329 (3.9) 6108 (4.0) 221 (2.5)
Asian or Pacific Islander 4158 (2.6) 4014 (2.6) 144 (1.6)
American Indian or Alaskan Native 703 (0.4) 669 (0.4) 34 (0.4)
Unknown 1830 (1.1) 1741 (1.1) 89 (1.0)
Missing 409 388 21
Education
High school diploma 35,962 (22.5) 34,184 (22.6) 1778 (20.3) <0.001
Some college/vocational school 60,610 (37.9) 57,318 (38.0) 3292 (37.7)
College degree or higher 63,151 (39.5) 59,483 (39.4) 3668 (42.0)
Missing 1207 1153 54
Clinical trial participant
No 93,049 (57.8) 87,981 (57.8) 5068 (57.6) 0.731
Yes 67,881 (42.2) 64,157 (42.2) 3724 (42.4)
Body mass index (kg/m2)
Mean SD 28.0 (5.9) 28.0 (6.0) 27.3 (5.5) <0.001
Underweight (<18.5) 1390 (0.9) 1307 (0.9) 83 (1.0) <0.001
Normal (18.5–24.9) 54,697 (34.3) 51,443 (34.1) 3254 (37.4)
Overweight (25.0–29.9) 55,419 (34.7) 52,265 (34.7) 3154 (36.2)
Obesity I (30.0–34.9) 29,547 (18.5) 28,110 (18.6) 1437 (16.5)
Obesity II (35.0–39.9) 12,089 (7.6) 11,552 (7.7) 537 (6.2)
Extreme Obesity III (40) 6377 (4.0) 6134 (4.1) 243 (2.8)
Missing 1411 1327 84
Use of estrogen alone or estrogenþprogestogen
Never used 70,390 (43.8) 66,076 (43.5) 4314 (49.1) <0.001
Past userc 25,794 (16.0) 24,189 (15.9) 1605 (18.3)
Current user 64,607 (40.2) 61,743 (40.6) 2864 (32.6)
Missing 139 130 9
Fracture at age 55þ years
No 102,551 (71.2) 97,563 (71.5) 4988 (65.5) <0.001
Yes 20,130 (14.0) 18,366 (13.5) 1764 (23.2)
Age <55 years 21,430 (14.9) 20,570 (15.1) 860 (11.3)
Missing 16,819 15,639 1180
Falls (last 12 months)
None 104,167 (67.5) 99,060 (67.9) 5107 (60.8) <0.001
1 time 30,952 (20.1) 29,067 (19.9) 1885 (22.4)
2 times 12,810 (8.3) 11,909 (8.2) 901 (10.7)
3 or more times 6442 (4.2) 5934 (4.1) 508 (6.0)
Missing 6559 6168 391
Alcohol intake
Non-drinker 17,498 (11.0) 16,535 (10.9) 963 (11.1) <0.001
Past drinker 29,884 (18.7) 28,458 (18.8) 1426 (16.4)
<1 drink per month 19,838 (12.4) 18,774 (12.4) 1064 (12.2)
<1 drink per week 32,782 (20.5) 31,026 (20.5) 1756 (20.2)
continued
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Table S1). Mean follow-up duration (standard deviation) was
11.8 (3.4) years, during which 8792 wrist fractures occurred.
Baseline characteristics of the analytic sample were similar to
those of excluded participants, but a lower proportion of the
included participants were black (9% versus 17%) or Hispanic
(4% versus 18%), had less than high school education (23%
versus 35%), were nonusers of menopausal hormone therapy
(40% versus 28%), did not consume alcohol (11% versus 18%),
did not regularly perform moderate-strenuous activity (16%
versus 24%), or had family income less than $10,000/yr
(4% versus 15%) (data not shown).
Absolute (unadjusted) risks of fracture (rates per 1000 person-
years) during the follow-up period, stratified by age, are
displayed in Table 2. The rate of any incident non-wrist fracture
was higher among women who had previously experienced
incident wrist fracture (36.0 per 1000 person-years) than among
women who had not previously experienced wrist fracture (19.5
per 1000 person-years) during the follow-up period. The rates of
clinical spine fracture, humerus fracture, upper extremity
(non-wrist) fracture, lower extremity fracture, and hip fracture
were each higher amongwomenwho had experienced previous
wrist fracture than among women who did not experience
previous wrist fracture. For all fracture types, fracture rates were
higher in older than younger age groups.
Within 10 years of initial wrist fracture, the proportion of
participants who subsequently experienced non-wrist fracture
were: clinical spine 6.8%, humerus 6.0%, upper extremity
non-wrist fracture 9.4%, lower extremity non-hip 12.6%, and
hip 4.9% (Table 3).
Adjusted associations between initial wrist fracture and
subsequent non-wrist fracture
After adjustment for age, race/ethnicity, and BMI, the hazard
ratio (HR) for non-wrist fractures was higher among parti-
cipants who had experienced initial wrist fracture than among
participants who had not experienced an initial wrist fracture
(Table 4). This was true for non-wrist fracture overall (HR¼ 1.40,
95% confidence interval [CI] 1.33–1.48), spine (HR¼ 1.48, 95%
CI 1.32–1.66), humerus (HR¼ 1.78, 95% CI 1.57–2.02), upper
extremity (non-wrist) (HR¼ 1.88, 95% CI 1.70–2.07), lower
extremity (non-hip) (HR¼ 1.36, 95% CI 1.26–1.48), and hip
Table 1. (Continued)
Wrist fractureb
Total No Yes
160,930 152,138 8792
N (%) n (%) n (%) p Value
1 to <7 drinks per week 41,029 (25.7) 38,634 (25.6) 2395 (27.5)
7þdrinks per week 18,692 (11.7) 17,583 (11.6) 1109 (12.7)
Missing 1207 1128 79
Smoking status
Never smoked 81,007 (51.0) 76,612 (51.0) 4395 (50.7) 0.004
Past smoker 66,783 (42.0) 63,037 (42.0) 3746 (43.2)
Current smoker 11,048 (7.0) 10,512 (7.0) 536 (6.2)
Missing 2,092 1,977 115
Total MET-hours per week
Mean SD 12.4 (13.7) 12.4 (13.7) 13.3 (14.0) <0.001
Quartile 1 38,858 (25.3) 36,973 (25.5) 1885 (22.7) <0.001
Quartile 2 37,765 (24.6) 35,807 (24.7) 1958 (23.6)
Quartile 3 38,309 (25.0) 36,128 (24.9) 2181 (26.2)
Quartile 4 38,566 (25.1) 36,281 (25.0) 2285 (27.5)
Missing 7432 6949 483
Supplemental calcium (mg)
Mean SD 354.9 (569.9) 353.5 (571.4) 379.4 (542.7) <0.001
Missing 2 2 0
Supplemental vitamin D (IU)
Mean SD 196 (248) 195 (247) 209 (249) <0.001
None 83,741 (52.0) 79,404 (52.2) 4337 (49.3) <0.001
<400 IU 16,227 (10.1) 15,304 (10.1) 923 (10.5)
400 IU 45,427 (28.2) 42,853 (28.2) 2574 (29.3)
>400 IU 15,533 (9.7) 14,575 (9.6) 958 (10.9)
Missing 2 2 0
Bisphosphonates
No 157,773 (98.0) 149,252 (98.1) 8521 (96.9) <0.001
Yes 3155 (2.0) 2884 (1.9) 271 (3.1)
Missing 2 2 0
MET¼metabolic equivalent of task.
aValues expressed as n (%) unless otherwise noted.
bIncludes wrist fractures (radius, ulna, carpal bones) through the end of WHI extension phase.
cPast hormone therapy use was defined as the use of an estrogen- or progestogen-containing pill or transdermal patch for 3 months or longer after
menopause.
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(HR¼ 1.50, 95% CI 1.32–1.71) fracture. The HR values remained
nearly identical after additional adjustment for other
covariates.
Associations between initial wrist fracture and subsequent
non-wrist fracture varied according to participant race/ethnicity
(interaction p value¼ 0.03), with stronger magnitudes of
associations in Hispanic/Latino women than in non-Hispanic
white or black women (Supplemental Table S2). Associations
between initial wrist fracture and subsequent non-wrist fracture
also differed by age at the time of wrist fracture, with stronger
associations among younger than among older women
(interaction p value¼ 0.02). HRs ranged from 1.24 (1.11–1.39)
among women aged 80 years and older to 2.49 (1.18–5.24)
among women aged <55 years.
Fig. 2 illustrates the time to non-wrist fracture (Fig. 2A),
humerus fracture (Fig. 2B), hip fracture (Fig. 2C), and spine
fracture (Fig. 2D), according to presence and absence of initial
wrist fracture. The difference in the cumulative incidence of
fractures over time in women with versus without initial wrist
fracture is evident for each fracture type.
In a sensitivity analysis excluding data from women who
reported use of osteoporosismedication any time during follow-
up, participants who self-initiated menopausal hormone thera-
py at any time during the study period, as well as participants
assigned to the active arms of the WHI Hormone Therapy and
WHI/CaD Trials, hazard ratios were slightly attenuated in
magnitude but were similar to those in the primary analysis
(data not shown).
Table 3. Proportion ofWomenWith Subsequent FractureWithin
10 Years of Wrist Fracture, by Site, With 95% Confidence Interval
Humerus fracture 0.060 (0.052–0.068)
Upper extremity (non-wrist) fracture 0.094 (0.084–0.103)
Lower extremity fracture 0.126 (0.115–0.137)
Hip fracture 0.049 (0.042–0.056)
Spine fracture 0.068 (0.059–0.076)
Table 4. Associations Between Incident Wrist Fracture and Subsequent Fracture
Wrist fracture
No Yes
Total n Event HR (95% CI)
Any non-wrist fracture
Crude 160,930 33,979 1 (ref) 1.54 (1.46–1.62)
Model 1a 159,118 33,596 1 (ref) 1.40 (1.33–1.48)
Model 2b 139,790 29,540 1 (ref) 1.40 (1.32–1.49)
Model 3c 136,017 28,790 1 (ref) 1.37 (1.29–1.46)
Spine fracture
Crude 160,930 5373 1 (ref) 1.75 (1.57–1.96)
Model 1 159,118 5301 1 (ref) 1.48 (1.32–1.66)
Model 2 139,790 4658 1 (ref) 1.51 (1.34–1.70)
Model 3 136,017 4544 1 (ref) 1.46 (1.29–1.65)
Humerus fracture
Crude 160,930 4361 1 (ref) 1.99 (1.76–2.26)
Model 1 159,118 4309 1 (ref) 1.78 (1.57–2.02)
Model 2 139,790 3793 1 (ref) 1.72 (1.50–1.96)
Model 3 136,017 3676 1 (ref) 1.67 (1.46–1.92)
Upper extremity (non-wrist) fractured
Crude 160,930 7312 1 (ref) 2.06 (1.87–2.27)
Model 1 159,118 7228 1 (ref) 1.88 (1.70–2.07)
Model 2 139,790 6360 1 (ref) 1.85 (1.67–2.06)
Model 3 136,017 6184 1 (ref) 1.80 (1.62–2.01)
Lower extremity fracturee
Crude 160,930 15,034 1 (ref) 1.41 (1.30–1.53)
Model 1 159,118 14,867 1 (ref) 1.36 (1.26–1.48)
Model 2 139,790 13,051 1 (ref) 1.35 (1.24–1.48)
Model 3 136,017 12,718 1 (ref) 1.30 (1.19–1.43)
Hip fracture
Crude 160,930 3836 1 (ref) 1.97 (1.73–2.24)
Model 1 159,118 3801 1 (ref) 1.50 (1.32–1.71)
Model 2 139,790 3291 1 (ref) 1.51 (1.31–1.74)
Model 3 136,017 3186 1 (ref) 1.48 (1.28–1.71)
aModel 1 is adjusted for age, race, and BMI.
bModel 2 is adjusted for covariates in model 1 plus education, income, cigarette smoking status, pack-years of cigarette smoking, total metabolic
equivalent of task h/wk, dietary calcium intake, calcium supplement intake, dietary vitamin D intake, vitamin D supplement intake, WHI-Hormone
Therapy Trials treatment assignment, and WHI Dietary Modification Trial treatment assignment.
cModel 3 is adjusted for covariates in model 2 plus number of falls, alcohol intake, history of cancer, and physical function score.
dIncludes elbow, hand, upper arm/humerus, and shoulder fractures; excludes finger fractures.
eIncludes foot, knee/patella, upper leg, and lower leg/ankle fractures; excludes hip fractures.
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When we defined the outcome as time to fracture or death,
results were similar to those of the primary analyses; associations
between incident wrist fracture and subsequent non-wrist
fracture showed a pattern of higher hazard ratios among
younger age groups (Supplemental Table S3).
In a final sensitivity analysis, we examined associations
between wrist fracture and subsequent fracture among the
participants whose fractures had been confirmed by medical
record review. Magnitudes of associations were very similar to
those of the primary analyses (data not shown).
Secondary analyses: associations between initial wrist fracture
and subsequent non-wrist fracture after adjustment for BMD
Using Cox proportional hazards regression, we examined the
influence of adjustment for baseline femoral neck BMD on the
associations between wrist fracture and subsequent non-wrist
fracture (Supplemental Table S4). HRs for associations between
wrist fracture and subsequent non-wrist fracture in the BMD
sample were similar to those in the overall analytic sample. After
adjustment for age, race, and BMI, the incidence of any non-wrist
fracture was higher for participants who experienced initial wrist
fracture than for participants who did not experience initial
wrist fracture (HR¼ 1.42, 95% CI 1.16–1.74). After additional
adjustment for baseline femoral neck BMD, the associations
between wrist fracture and subsequent non-wrist fracture
remained significant (HR¼ 1.30, 95% CI 1.06–1.59), although
slightly decreased in magnitude. Associations between initial
wrist fracture and subsequent non-wrist fracture did not
significantly vary by baseline femoral neck BMD category.
Discussion
In this cohort, compared with postmenopausal women who did
not experience a wrist fracture during 11.8 years of follow-up,
those who experienced a wrist fracture during follow-up had a
markedly elevated risk of subsequent vertebral, humerus, upper
extremity (non-wrist), lower extremity (non-hip), and hip
fractures, with hazard ratios ranging from 1.36 (for lower
extremity non-hip fracture) to 1.88 (for upper extremity non-
wrist fracture). Participants who experienced wrist fracture
during follow-up were at 1.5-fold higher risk of subsequent hip
fracture. The association between initial wrist fracture and any
subsequent non-wrist fracture persisted after adjustment for
other osteoporosis risk factors and baseline femoral neck BMD.
To our knowledge, this study is the first large multisite
prospective US study that has focused on associations between
wrist fracture and subsequent incidence of upper extremity,
Fig. 2. (A) Cumulative incidence of non-wrist fracture in the presence and absence of initial wrist fracture during the WHI follow-up period (non-
parametric estimate). (B) Cumulative incidence of humerus fracture in the presence and absence of initial wrist fracture during the WHI follow-up period
(non-parametric estimate). (C) Cumulative incidence of hip fracture in the presence and absence of initial wrist fracture during the WHI follow-up period
(non-parametric estimate). (D) Cumulative incidence of spine fracture in the presence and absence of initial wrist fracture during the WHI follow-up
period (non-parametric estimate).
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lower extremity, and spine fracture. In a study of residents of
Rochester, MN, over a 7.5-year follow-up, womenwho had initial
distal forearm fracture had approximately a 5- to 6-fold increase
in subsequent vertebral fracture and a doubling of risk of
subsequent proximal femur fracture.(16) In the National
Osteoporosis Risk Assessment (NORA) study of women aged
50 years, during 3 years of follow-up, the risk of subsequent hip
fracture was higher among women with initial wrist
fracture.(17,18) As far as we are aware, patterns of other specific
types of fractures after initial wrist fracture have not yet been
reported in the NORA cohort.
The association between wrist fracture and increased risk of
subsequent non-wrist fracture persisted after adjustment for
BMD. This finding, combined with the observation that the
associations persisted despite adjustment for all known major
fracture risk factors, suggests that aberrations in bone structure
and/or strength are at least partly responsible for placing
women with wrist fracture at increased risk of subsequent
fracture. Frequency of falls did not account for the increased risk
of non-wrist fractures after a wrist fracture. Treatment guided by
spine and/or hip BMD measurements alone may underestimate
the increased risk of subsequent fracture risk in the setting of an
initial wrist fracture.
Clinical trials have not specifically tested fracture reduction
strategies that are tailored to women with wrist fracture who
have BMD T-scores between –1 and –2.5. A subgroup analysis
from the Fracture Intervention Trial focused on older women
with BMD T-scores between –1 and –2.5. In that subgroup of
women, the reduction in fracture risk after treatment with a
bisphosphonate (alendronate) was no greater in women with a
previous non-vertebral fracture (26% of which were wrist
fractures) than in women without a previous non-vertebral
fracture.(32)
Our results have clinical and public health implications. First,
clinicians should identify postmenopausal women with wrist
fractures as being at significantly elevated risk for multiple
types of future fracture, including hip fracture. Also, clinicians
should be aware the younger the woman is when she
experiences wrist fracture, the higher the relative risk of
subsequent fracture. In fully adjusted models, wrist fracture
was associated with a 37% higher relative risk of subsequent
non-wrist fracture, which was similar in magnitude to being
10 years older (35% higher). Fourth, the increased incidence of
non-wrist fractures after a wrist fracture highlight the need for
future studies that focus on developing and testing inter-
ventions specifically to prevent subsequent fractures after an
initial wrist fracture. There is currently no proven intervention
that specifically targets women with wrist fracture who have
normal lumbar spine and femoral neck BMD. Finally, the
elevated risk of subsequent fracture among postmenopausal
women with wrist fracture persisted even after we adjusted for
BMD, suggesting that the increased risk of subsequent
fractures is not entirely explained by spine and/or hip BMD
measurements.
Strengths of our study include the large sample size, the
prospective follow-up, and availability of detailed information
regarding major osteoporotic risk factors.
Our study has limitations. First, self-reported information
regarding fractures is not as accurate as medical record-verified
fractures. However, misclassification of fractures in WHI is low. In
a validation study in WHI, Chen and colleagues found that the
agreement between self-reports for single-site fractures and
medical records within the WHI was high for hip (78%) and
forearm/wrist (81%) but low for clinical spine fracture (51%),
and the average confirmation rate for all single-site fractures was
71%.(26) Second, WHI participants are likely healthier than
postmenopausal women in the general population andmay not
be representative of the general population of postmenopausal
women. Thus, associations between wrist fracture and
subsequent fracture may be stronger in the general population
than in our study participants. Third, the number of womenwith
wrist fractures and normal BMD was small. Fourth, although we
adjusted for multiple lifestyle-related risk factors (smoking, total
metabolic equivalent of task h/wk, calcium and vitamin D intake,
falls, alcohol intake), there may exist other lifestyle-related
causes of repeat fractures for which we lacked information.
Finally, we did not adjust for multiple comparisons, so the
probability of at least one of the reported confidence intervals
will exclude unity under an overall null hypothesis is greater
than 0.05.
In conclusion, nearly 1 in 5 women with initial wrist fracture
went on to experience a subsequent non-wrist fracture over
11 years of follow-up. Our results suggest substantial missed
opportunity for intervention in the large number of womenwho
presentwithwrist fractures to prevent subsequent fractures. Our
findings support the approach of the recent position statement
advocating that womenwithwrist fracture should undergo BMD
testing and that those with BMD T-score –1.0 should receive a
diagnosis of osteoporosis.(12) Studies should develop and test
interventions specifically targeted to women with sentinel
forearm fracture. Increased attention to wrist fracture as a
fragility fracture is important to allow the early identification of
women at risk for future fracture for preventive measures.
Disclosures
NCW and JRC have research contracts with Amgen, Inc. All other
authors state that they have no conflicts of interest.
Acknowledgments
The authors are grateful to the study participants for their
dedication to the study.
Short list of WHI investigators: Program office: (National Heart,
Lung, and Blood Institute, Bethesda, Maryland) Jacques
Rossouw, Shari Ludlam, Dale Burwen, Joan McGowan, Leslie
Ford, and Nancy Geller. Clinical coordinating center: (Fred
Hutchinson Cancer Research Center, Seattle, WA) Garnet
Anderson, Ross Prentice, Andrea LaCroix, and Charles Kooper-
berg. Investigators and academic centers: (Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA) JoAnn
E Manson; (MedStar Health Research Institute/Howard Universi-
ty, Washington, DC) Barbara V Howard; (Stanford Prevention
Research Center, Stanford, CA) Marcia L Stefanick; (The Ohio
State University, Columbus, OH) Rebecca Jackson; (University of
Arizona, Tucson/Phoenix, AZ) Cynthia A Thomson; (University at
Buffalo, Buffalo, NY) Jean Wactawski-Wende; (University of
Florida, Gainesville/Jacksonville, FL) Marian Limacher; (Universi-
ty of Iowa, Iowa City/Davenport, IA) Robert Wallace; (University
of Pittsburgh, Pittsburgh, PA) Lewis Kuller; (Wake Forest
University School of Medicine, Winston-Salem, NC) Sally Shu-
maker. Women’s Health Initiative Memory Study: (Wake Forest
University School of Medicine, Winston-Salem, NC) Sally Shu-
maker. For a list of all the investigators who have contributed to
WHI science, please visit: https://www.whi.org/researchers/
2094 CRANDALL ET AL. Journal of Bone and Mineral Research
Documents%20%20Write%20a%20Paper/WHI%20Investigator
%20Long%20List.pdf.
The WHI program is funded by the National Heart, Lung,
and Blood Institute, National Institutes of Health, US Department
of Health and Human Services through contracts
HHSN268201100046C, HHSN268201100001C, HHSN2682011
00002C, HHSN268201100003C, HHSN268201100004C, and HH
SN271201100004C.
Role of the sponsor: The Women’s Health Initiative (WHI)
project office at the National Heart, Lung, and Blood Institute
(NHLBI), which was the sponsor, had a role in the design and
conduct of the study and in the collection and management of
the data. The sponsor did not have a role in analysis and
interpretation of the data, the preparation of the manuscript, or
the decision to submit the manuscript for publication. Review
and approval of the manuscript was carried out by committees
composed of WHI investigators and NHLBI representatives.
Resource sharing: The Women’s Health Initiative Study data
are available via the BioLINCC website of the National Heart,
Lung, and Blood Institute at https://biolincc.nhlbi.nih.gov/
home/.
Authors’ roles: Study conception and design: CJC and MSL.
Acquisition of data: JWW. Statistical analysis: CA and KH. Data
interpretation: all authors. Drafting of manuscript: CJC. Critical
revision of manuscript for important intellectual content: all
authors.
References
1. Owen RA, Melton LJ 3rd, Ilstrup DM, Johnson KA, Riggs BL. Colles’
fracture and subsequent hip fracture risk. Clin Orthop Relat Res. 1982
(171):37–43.
2. Melton LJ 3rd, Christen D, Riggs BL, et al. Assessing forearm fracture
risk in postmenopausal women. Osteoporos Int. 2010;21(7):1161–9.
3. Orces CH, Martinez FJ. Epidemiology of fall related forearm andwrist
fractures among adults treated in US hospital emergency depart-
ments. Inj Prev. 2011;17(1):33–6.
4. Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA.
Symptomatic fracture incidence in elderly men and women: the
Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int.
1994;4(5):277–82.
5. Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd. Trends in
fracture incidence: a population-based study over 20 years. J Bone
Miner Res. 2014;29(3):581–9.
6. Rosengren BE, Karlsson M, Petersson I, Englund M. The 21st-century
landscape of adult fractures: cohort study of a complete adult
regional population. J Bone Miner Res. 2015;30(3):535–42.
7. Black DM, Cooper C. Epidemiology of fractures and assessment of
fracture risk. Clin Lab Med. 2000;20(3):439–53.
8. Cerocchi I, Ghera S, Gasbarra E, Feola M, Tarantino U. The clinical
significance of wrist fracture in osteoporosis. Aging Clin Exp Res.
2013;25(Suppl 1):S81–2.
9. Edwards BJ, Song J, Dunlop DD, Fink HA, Cauley JA. Functional
decline after incident wrist fractures—Study of Osteoporotic
Fractures: prospective cohort study. BMJ. 2010;341:c3324.
10. Curtis JR, Arora T, Matthews RS, et al. Is withholding osteoporosis
medication after fracture sometimes rational? A comparison of the
risk for second fracture versus death. J Am Med Dir Assoc.
2010;11(8):584–91.
11. National Osteoporosis Foundation. Clinician’s guide to prevention
and treatment of osteoporosis. Washington, DC: National Osteopo-
rosis Foundation; 2014.
12. Siris ES, Adler R, Bilezikian J, et al. The clinical diagnosis of
osteoporosis: a position statement from the National Bone Health
Alliance Working Group. Osteoporos Int. 2014;25(5):1439–43.
13. Gay JD. Radial fracture as an indicator of osteoporosis: a 10-year
follow-up study. Can Med Assoc J. 1974;111(2):156–7.
14. Chen CW, Huang TL, Su LT, et al. Incidence of subsequent hip
fractures is significantly increased within the first month after distal
radius fracture in patients older than 60 years. J Trauma Acute Care
Surg. 2013;74(1):317–21.
15. Lauritzen JB, Schwarz P, McNair P, Lund B, Transbol I. Radial and
humeral fractures as predictors of subsequent hip, radial or humeral
fractures in women, and their seasonal variation. Osteoporos Int.
1993;3(3):133–7.
16. Cuddihy MT, Gabriel SE, Crowson CS, O’Fallon WM, Melton LJ 3rd.
Forearm fractures as predictors of subsequent osteoporotic
fractures. Osteoporos Int. 1999;9(6):469–75.
17. Barrett-Connor E, Sajjan SG, Siris ES, Miller PD, Chen YT, Markson
LE. Wrist fracture as a predictor of future fractures in younger
versus older postmenopausal women: results from the National
Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2008;19-
(5):607–13.
18. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture
outcomes of undiagnosed low bone mineral density in postmeno-
pausal women: results from the National Osteoporosis Risk
Assessment. JAMA. 2001;286(22):2815–22.
19. Design of the Women’s Health Initiative clinical trial and
observational study. The Women’s Health Initiative Study Group.
Control Clin Trials. 1998;19(1):61–109.
20. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M.
The Women’s Health Initiative Observational Study: baseline
characteristics of participants and reliability of baseline measures.
Ann Epidemiol. 2003;13(9 Suppl):S107–21.
21. Cauley JA, Wampler NS, Barnhart JM, et al. Incidence of fractures
compared to cardiovascular disease and breast cancer: theWomen’s
Health Initiative Observational Study. Osteoporos Int. 2008;19-
(12):1717–23.
22. Anderson GL, Manson J, Wallace R, et al. Implementation of the
Women’s Health Initiative study design. Ann Epidemiol. 2003;13(9
Suppl):S5–17.
23. Beck TJ, Petit MA, Wu G, LeBoff MS, Cauley JA, Chen Z. Does obesity
really make the femur stronger? BMD, geometry, and fracture
incidence in the Women’s Health Initiative observational study.
J Bone Miner Res. 2009;24(8):1369–79.
24. LaCroix AZ, Beck TJ, Cauley JA, et al. Hip structural geometry and
incidence of hip fracture in postmenopausal women: what does it
add to conventional bone mineral density? Osteoporos Int.
2010;21(6):919–29.
25. Chen Z, Arendell L, Aickin M, et al. Hip bone density predicts breast
cancer risk independently of Gail score: results from the Women’s
Health Initiative. Cancer. 2008;113(5):907–15.
26. Chen Z, Kooperberg C, Pettinger MB, et al. Validity of self-report for
fractures among a multiethnic cohort of postmenopausal women:
results from the Women’s Health Initiative observational study and
clinical trials. Menopause. 2004;11(3):264–74.
27. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with
vigorous exercise for the prevention of cardiovascular events in
women. N Engl J Med. 2002;347(10):716–25.
28. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-
Collins T. Measurement characteristics of the Women’s Health
Initiative food frequency questionnaire. Ann Epidemiol. 1999;9-
(3):178–87.
29. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health
survey (SF-36). I. Conceptual framework and item selection. Med
Care. 1992;30(6):473–83.
30. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health
Survey 1. 0. Health Econ. 1993;2(3):217–27.
31. Kanis JA, Johnell O, Oden A, JohanssonH,McCloskey E. FRAX and the
assessment of fracture probability in men and women from the UK.
Osteoporos Int. 2008;19(4):385–97.
32. Ryder KM, Cummings SR, Palermo L, et al. Does a history of non-
vertebral fracture identify women without osteoporosis for
treatment? J Gen Intern Med. 2008;23(8):1177–81.
Journal of Bone and Mineral Research WRIST FRACTURE AND SUBSEQUENT FRACTURE 2095
